Gemcitabine Monotherapy Associated with Posterior Reversible Encephalopathy Syndrome

被引：15

作者：

Porcello Marrone, Luiz Carlos ^{[1
,2
,4
,6
]}

Marrone, Bianca Fontana ^{[5
]}

Raya, Julia de la Puerta ^{[4
]}

Gadonski, Giovani ^{[2
,4
]}

da Costa, Jaderson Costa ^{[1
,3
,4
]}

机构：

[1] Pontificiae Univ Catolica Rio Grande do Sul, Inst Cerebro, Porto Alegre, RS, Brazil

[2] Pontificiae Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Porto Alegre, RS, Brazil

[3] Pontificiae Univ Catolica Rio Grande do Sul, Fac Med, Dept Neurol, Porto Alegre, RS, Brazil

[4] Pontificiae Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil

[5] Hosp Clin Porto Alegre, Dept Oncol, Porto Alegre, RS, Brazil

[6] Pontificiae Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Inst Cerebro, BR-90160090 Porto Alegre, RS, Brazil

来源：

CASE REPORTS IN ONCOLOGY | 2011年 / 4卷 / 01期

关键词：

Posterior reversible encephalopathy syndrome; Gemcitabine; Chemotherapy;

D O I：

10.1159/000324581

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome.

引用

页码：82 / 87

页数：6

共 50 条

[1] A Case of Gemcitabine and Cisplatin Associated Posterior Reversible Encephalopathy Syndrome
Kwon, Eun Jin
Kim, Se Won
Kim, Kwang Ki
Seo, Hyung Suk
Kim, Do Yeun
CANCER RESEARCH AND TREATMENT, 2009, 41 (01): : 53 - 55
[2] Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin
R. Dersch
O. Stich
K. Goller
S. Meckel
F. Dechent
S. Doostkam
C. Weiller
J. Bardutzky
Journal of Neurology, 2013, 260 : 1406 - 1407
[3] Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin
Dersch, R.
Stich, O.
Goller, K.
Meckel, S.
Dechent, F.
Doostkam, S.
Weiller, C.
Bardutzky, J.
JOURNAL OF NEUROLOGY, 2013, 260 (05) : 1406 - 1407
[4] Gemcitabine/oxaliplatinDelayed posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2007, 1162 (1) : 17 - 17
[5] Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome
Schaub, John R.
Tang, Shou-Ching
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (06) : 795 - 798
[6] Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings
Russell, MT
Nassif, AS
Cacayorin, ED
Awwad, E
Perman, W
Dunphy, F
MAGNETIC RESONANCE IMAGING, 2001, 19 (01) : 129 - 132
[7] Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature
Kabre, Rohit Santosh
Kamble, Krishna Marotirao
JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2016, 5 (04) : 297 - 300
[8] Posterior reversible encephalopathy syndrome associated with cyclic vomiting syndrome
Iio, Kyohei
Kawasaki, Yu
Iwata, Aya
Yamaguchi, Yoshimichi
Hiraumi, Yoshimi
Matsubara, Kousaku
PEDIATRICS INTERNATIONAL, 2023, 65 (01)
[9] Rheumatic Diseases Associated With Posterior Reversible Encephalopathy Syndrome
Manadan, Augustine
Kambhatla, Soumyasri
Gauto-Mariotti, Estefania
Okoli, Chimuanya
Block, Joel A.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (08) : E391 - E394
[10] Posterior Reversible Encephalopathy Syndrome Associated With Coarctation of the Aorta
Bilitardo, Isabella O.
Watashi, Diego M.
Sene, Diogo R.
Teixeira, George S.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)

← 1 2 3 4 5 →